- Corporate Officers - R
- Rakin Kevin
Insider Trading History of Rakin Kevin
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rakin Kevin since 2006.
This trader's CIK number is 1184421.
At the time of last reporting, Rakin Kevin was the Officer of Oramed Pharmaceuticals Inc.. (stock ticker symbol ORMP).
Also see all insider trading activities at Oramed Pharmaceuticals Inc..
Note that in the past
RAKIN KEVIN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Aziyo Biologics, Inc. (AZYO) by Rakin Kevin
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | AZYO | 412,735 | $1,749,996 | 0 | $0 | 0 | $0 |
2020 | AZYO | 441,176 | $7,499,992 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Omrix Biopharmaceuticals, Inc. (OMRI) by Rakin Kevin
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2008 | OMRI | 2,000 | $27,292 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vion Pharmaceuticals Inc (VION) by Rakin Kevin
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | VION | 15,000 | $23,850 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ocugen, Inc. (HSGX) by Rakin Kevin
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | HSGX | 0 | $0 | 0 | $0 | 350,853 | $0 |
2018 | HSGX | 230,768 | $0 | 0 | $0 | 0 | $0 |
2014 | HSGX | 11,237 | $123,607 | 17 | $187 | 0 | $0 |
Yearly summary of insider trading at Oramed Pharmaceuticals Inc. (ORMP) by Rakin Kevin
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | ORMP | 0 | $0 | 10,000 | $94,100 | 6,667 | $32,001 |
2021 | ORMP | 0 | $0 | 21,100 | $442,825 | 79,136 | $454,478 |
Yearly summary of insider trading at Clinical Data Inc (CLDA) by Rakin Kevin
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | CLDA | 0 | $0 | 10,000 | $161,680 | 0 | $0 |
Insider trading activities at 6 companies by Rakin Kevin:
1. Aziyo Biologics, Inc. (AZYO)
2. Omrix Biopharmaceuticals, Inc. (OMRI)
3. Vion Pharmaceuticals Inc (VION)
4. Ocugen, Inc. (HSGX)
5. Oramed Pharmaceuticals Inc. (ORMP)
6. Clinical Data Inc (CLDA)
Table 1. Insider trading of Aziyo Biologics, Inc. (AZYO) by Rakin Kevin
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-12-08 | AZYO | Buy | 412,735 | 4.24 | 1,749,996 |
2020-10-13 | AZYO | Buy | 441,176 | 17.00 | 7,499,992 |
Table 2. Insider trading of Omrix Biopharmaceuticals, Inc. (OMRI) by Rakin Kevin
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2008-03-26 | OMRI | Buy | 2,000 | 13.65 | 27,292 |
Table 3. Insider trading of Vion Pharmaceuticals Inc (VION) by Rakin Kevin
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-03-13 | VION | Buy | 15,000 | 1.59 | 23,850 |
Table 4. Insider trading of Ocugen, Inc. (HSGX) by Rakin Kevin
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-02-08 | HSGX | Option Ex | 350,853 | .00 | 0 |
2018-10-10 | HSGX | Buy | 230,768 | .00 | 0 |
2014-12-08 | HSGX | Buy | 11,237 | 11.00 | 123,607 |
2014-12-08 | HSGX | Sale | 17 | 11.00 | 187 |
Table 5. Insider trading of Oramed Pharmaceuticals Inc. (ORMP) by Rakin Kevin
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-03-21 | ORMP | Sale | 10,000 | 9.41 | 94,100 |
2022-02-17 | ORMP | Option Ex | 6,667 | 4.80 | 32,001 |
2021-09-16 | ORMP | Sale | 21,100 | 20.99 | 442,825 |
2021-08-09 | ORMP | Option Ex | 79,136 | 5.74 | 454,478 |
Table 6. Insider trading of Clinical Data Inc (CLDA) by Rakin Kevin
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-11-20 | CLDA | Sale | 10,000 | 16.17 | 161,680 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Rakin Kevin
(Officer of Oramed Pharmaceuticals Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.